155 related articles for article (PubMed ID: 12704366)
1. Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction.
Crimi N; Pagano C; Palermo F; Mastruzzo C; Prosperini G; Pistorio MP; Vancheri C
J Allergy Clin Immunol; 2003 Apr; 111(4):833-9. PubMed ID: 12704366
[TBL] [Abstract][Full Text] [Related]
2. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
[TBL] [Abstract][Full Text] [Related]
3. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
4. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
Schelfhout V; Van De Velde V; Pauwels R; Joos G
Pulm Pharmacol Ther; 2008; 21(2):276-84. PubMed ID: 17611132
[TBL] [Abstract][Full Text] [Related]
5. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.
Reiss TF; Hill JB; Harman E; Zhang J; Tanaka WK; Bronsky E; Guerreiro D; Hendeles L
Thorax; 1997 Dec; 52(12):1030-5. PubMed ID: 9516894
[TBL] [Abstract][Full Text] [Related]
6. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
7. The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics.
Joos GF; Van Schoor J; Kips JC; Pauwels RA
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1781-4. PubMed ID: 8665034
[TBL] [Abstract][Full Text] [Related]
8. Time-effect of montelukast on protection against exercise-induced bronchoconstriction.
Peroni DG; Pescollderungg L; Sandri M; Chinellato I; Boner AL; Piacentini GL
Respir Med; 2011 Dec; 105(12):1790-7. PubMed ID: 21865022
[TBL] [Abstract][Full Text] [Related]
9. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.
Bronsky EA; Kemp JP; Zhang J; Guerreiro D; Reiss TF
Clin Pharmacol Ther; 1997 Nov; 62(5):556-61. PubMed ID: 9390112
[TBL] [Abstract][Full Text] [Related]
10. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor.
Casas A; Gómez FP; Dahlén B; Roca J; Barberà JA; Dahlén SE; Rodríguez-Roisin R
Eur Respir J; 2005 Sep; 26(3):442-8. PubMed ID: 16135725
[TBL] [Abstract][Full Text] [Related]
12. Protection of nedocromil sodium on bronchoconstriction induced by inhaled neurokinin A (NKA) in asthmatic patients.
Crimi N; Palermo F; Oliveri R; Palermo B; Polosa R; Mistretta A
Clin Exp Allergy; 1992 Jan; 22(1):75-81. PubMed ID: 1312888
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide.
Gong H; Linn WS; Terrell SL; Anderson KR; Clark KW
Chest; 2001 Feb; 119(2):402-8. PubMed ID: 11171715
[TBL] [Abstract][Full Text] [Related]
14. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
Gaszczyk G; Latoś T; Słowikowski A; Janiak B
Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
[TBL] [Abstract][Full Text] [Related]
15. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
16. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.
Kim JH; Lee SY; Kim HB; Kim BS; Shim JY; Hong TJ; Hong SJ
Pediatr Pulmonol; 2005 Feb; 39(2):162-6. PubMed ID: 15633203
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene E
Lazarinis N; Bood J; Gomez C; Kolmert J; Lantz AS; Gyllfors P; Davis A; Wheelock CE; Dahlén SE; Dahlén B
J Allergy Clin Immunol; 2018 Oct; 142(4):1080-1089. PubMed ID: 29518425
[TBL] [Abstract][Full Text] [Related]
18. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
Harrison S; Gatti R; Baraldo S; Oliani KL; Andre E; Trevisani M; Gazzieri D; Saetta M; Geppetti P
Pulm Pharmacol Ther; 2008; 21(2):317-23. PubMed ID: 17905619
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma.
Kazani S; Sadeh J; Bunga S; Wechsler ME; Israel E
Respir Med; 2011 May; 105(5):667-73. PubMed ID: 21169002
[TBL] [Abstract][Full Text] [Related]
20. Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs.
Ishimura M; Suda M; Morizumi K; Kataoka S; Maeda T; Kurokawa S; Hiyama Y
Br J Pharmacol; 2008 Feb; 153(4):669-75. PubMed ID: 18037905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
